A detailed history of Arizona State Retirement System transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 39,826 shares of IBRX stock, worth $178,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,826
Previous 37,735 5.54%
Holding current value
$178,818
Previous $238,000 38.24%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.32 - $6.7 $6,942 - $14,009
2,091 Added 5.54%
39,826 $147,000
Q2 2024

Aug 05, 2024

BUY
$4.82 - $9.15 $4,988 - $9,470
1,035 Added 2.82%
37,735 $238,000
Q1 2024

May 07, 2024

SELL
$3.23 - $6.17 $2,015 - $3,850
-624 Reduced 1.67%
36,700 $197,000
Q4 2023

Jan 24, 2024

BUY
$1.25 - $5.21 $103 - $432
83 Added 0.22%
37,324 $187,000
Q3 2023

Nov 06, 2023

BUY
$1.29 - $3.1 $665 - $1,599
516 Added 1.41%
37,241 $62,000
Q2 2023

Aug 01, 2023

BUY
$1.53 - $6.41 $2,949 - $12,358
1,928 Added 5.54%
36,725 $102,000
Q1 2023

Apr 27, 2023

BUY
$1.35 - $4.78 $1,228 - $4,349
910 Added 2.69%
34,797 $63,000
Q4 2022

Feb 07, 2023

BUY
$4.35 - $6.77 $6,281 - $9,775
1,444 Added 4.45%
33,887 $171,000
Q3 2022

Nov 07, 2022

BUY
$3.65 - $6.43 $372 - $655
102 Added 0.32%
32,443 $161,000
Q2 2022

Jul 28, 2022

BUY
$2.68 - $6.14 $29,067 - $66,594
10,846 Added 50.46%
32,341 $120,000
Q1 2022

May 04, 2022

BUY
$5.05 - $7.53 $2,216 - $3,305
439 Added 2.08%
21,495 $121,000
Q4 2021

Feb 04, 2022

BUY
$5.67 - $10.18 $799 - $1,435
141 Added 0.67%
21,056 $128,000
Q3 2021

Nov 12, 2021

BUY
$9.17 - $14.24 $96,697 - $150,160
10,545 Added 101.69%
20,915 $204,000
Q2 2021

Aug 02, 2021

BUY
$13.41 - $22.4 $11,894 - $19,868
887 Added 9.35%
10,370 $148,000
Q1 2021

May 06, 2021

BUY
$12.83 - $42.25 $121,666 - $400,656
9,483 New
9,483 $225,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.8B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.